Clinical Evaluation of a Restorative Glass Ionomer and a Composite Resin for the Restoration
NCT ID: NCT04266210
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-10-01
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After recruiting participants with at least 2 NCCLs and at least one systemic disease, all restorations will be placed by a single clinician. All lesions will be cleaned before restoring.
NCCLs will be divided into two groups: a conventional restorative glass ionomer cement \[Fuji Bulk (GC, Tokyo Japan) (FB)\] and a posterior composite resin \[G-ænial Posterior (GC, Tokyo Japan) (GP)\] All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using modified United States Public Health Service (USPHS) criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of a Restorative Glass Ionomer and a Bulk-fill Composite Resin
NCT04685967
Clinical Performance of Injectable Composite Resins in Class I Cavities
NCT06192667
Clinical Evaluation of Bulk-fill Restorative Materials
NCT06109987
Comparative Evaluation of an Alkasite-based Restorative Material and Two Different Resin Composites
NCT06375837
Clinical Performance of Different Resin Cements
NCT04694690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fuji Bulk
Glass ionomer (Fuji Bulk, GC, Tokyo Japan)
Fuji Bulk
Restorative system
G-ænial Posterior
Posterior composite resin(G-ænial Posterior, GC, Tokyo Japan)
G-ænial Posterior
Restorative system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fuji Bulk
Restorative system
G-ænial Posterior
Restorative system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patients using medications for hypertension, diabetes mellitus, hemophilia, heart disease, coronary artery disease, rheumatoid arthritis, chronic obstructive pulmonary disease, lupus eritematozus.
Patients who are able to attend recall appointments.
Age greater than 18 years who had at least one systemic disease At least two NCCLs needed to be restored.
At least 20 teeth in occlusion.
Exclusion Criteria
Mobility of teeth
Severe periodontal disease
Heavy bruxism habit
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Fatma Dilşad Öz
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Glass ionomer - Composite
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.